Blockade of IL-6R using tocilizumab to treat RA led to sustained increase in circulating Treg levels during the therapy suggesting that IL-6 inhibition may improve the Th17/Treg balance in kidney transplantation as well (173, 174). Here, IL6R is linked to rheumatoid arthritis.